EE200200189A - Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt - Google Patents

Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Info

Publication number
EE200200189A
EE200200189A EEP200200189A EEP200200189A EE200200189A EE 200200189 A EE200200189 A EE 200200189A EE P200200189 A EEP200200189 A EE P200200189A EE P200200189 A EEP200200189 A EE P200200189A EE 200200189 A EE200200189 A EE 200200189A
Authority
EE
Estonia
Prior art keywords
leptin
vector
substance
determination
assay kit
Prior art date
Application number
EEP200200189A
Other languages
English (en)
Estonian (et)
Inventor
Rubinstein Menachem
Cohen Batya
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200200189A publication Critical patent/EE200200189A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
EEP200200189A 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt EE200200189A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13231399A IL132313A0 (en) 1999-10-11 1999-10-11 Leptin assay
PCT/IL2000/000621 WO2001027319A2 (fr) 1999-10-10 2000-10-05 Dosage de la leptine

Publications (1)

Publication Number Publication Date
EE200200189A true EE200200189A (et) 2003-06-16

Family

ID=11073317

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200189A EE200200189A (et) 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Country Status (24)

Country Link
US (1) US7247427B1 (fr)
EP (1) EP1222467B1 (fr)
JP (1) JP2003511057A (fr)
KR (1) KR100863580B1 (fr)
CN (1) CN1159585C (fr)
AR (1) AR025995A1 (fr)
AT (1) ATE322017T1 (fr)
AU (1) AU778727B2 (fr)
BR (1) BR0014626A (fr)
CA (1) CA2386365A1 (fr)
CY (1) CY1105025T1 (fr)
DE (1) DE60027031T2 (fr)
DK (1) DK1222467T3 (fr)
EA (1) EA004709B1 (fr)
EE (1) EE200200189A (fr)
ES (1) ES2256045T3 (fr)
HK (1) HK1048514B (fr)
IL (2) IL132313A0 (fr)
NO (1) NO20021604D0 (fr)
PT (1) PT1222467E (fr)
SI (1) SI1222467T1 (fr)
UA (1) UA77153C2 (fr)
WO (1) WO2001027319A2 (fr)
ZA (1) ZA200202155B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2372364A1 (fr) * 2010-03-31 2011-10-05 Medizinische Hochschule Hannover Biomarqueur pour hypertension pulmonaire
PT2661266T (pt) 2011-01-07 2020-11-30 Anji Pharma Us Llc Terapias com base em ligandos do recetor quimiossensorial
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
CN102221615A (zh) * 2011-03-31 2011-10-19 广州华灿医药科技有限公司 一种基于Angiogenin检测的双抗夹心ELISA方法
SG10201901922VA (en) 2012-01-06 2019-04-29 Elcelyx Therapeutics Inc Compositions and methods for treating metabolic disorders
MX2014008190A (es) 2012-01-06 2015-02-04 Elcelyx Therapeutics Inc Composiciones de biguanida y métodos para tratar transtornos metabólicos.
WO2013158928A2 (fr) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Thérapies à base de ligand de récepteur chimiosensoriels
HK1210825A1 (en) 2012-07-11 2016-05-06 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN102901823A (zh) * 2012-10-26 2013-01-30 安徽安科生物工程（集团）股份有限公司 瘦素检测试剂盒
EA039530B1 (ru) 2013-01-05 2022-02-08 Анджи Фарма (Юс) Элэлси Композиция с отсроченным высвобождением, содержащая бигуанид
CN104459105B (zh) * 2014-12-05 2016-03-09 重庆中元生物技术有限公司 一种检测lp的胶乳增强免疫比浊试剂盒及其制备方法
CN115901697B (zh) * 2021-08-26 2026-03-17 苏州生物医药转化工程中心 一种检测瘦素相关蛋白或其类似物的活性的方法
CN114940717B (zh) * 2022-06-30 2024-04-26 武汉海特生物制药股份有限公司 嵌合受体、32d瘦素敏感细胞株及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914611A4 (fr) 1996-04-22 2002-10-16 Merck & Co Inc Dosage de la leptine

Also Published As

Publication number Publication date
IL132313A0 (en) 2001-03-19
UA77153C2 (en) 2006-11-15
WO2001027319A2 (fr) 2001-04-19
JP2003511057A (ja) 2003-03-25
ZA200202155B (en) 2003-05-28
CA2386365A1 (fr) 2001-04-19
DE60027031D1 (de) 2006-05-18
HK1048514B (zh) 2004-12-31
KR20020048416A (ko) 2002-06-22
US7247427B1 (en) 2007-07-24
WO2001027319A3 (fr) 2001-06-21
DK1222467T3 (da) 2006-08-07
EP1222467A2 (fr) 2002-07-17
IL149021A (en) 2007-12-03
EA200200435A1 (ru) 2002-10-31
AU778727B2 (en) 2004-12-16
PT1222467E (pt) 2006-06-30
EA004709B1 (ru) 2004-06-24
AR025995A1 (es) 2002-12-26
ES2256045T3 (es) 2006-07-16
AU7814100A (en) 2001-04-23
IL149021A0 (en) 2002-11-10
ATE322017T1 (de) 2006-04-15
KR100863580B1 (ko) 2008-10-15
CN1159585C (zh) 2004-07-28
NO20021604L (no) 2002-04-04
CY1105025T1 (el) 2010-03-03
DE60027031T2 (de) 2006-08-24
CN1378648A (zh) 2002-11-06
NO20021604D0 (no) 2002-04-04
BR0014626A (pt) 2002-06-11
EP1222467B1 (fr) 2006-03-29
HK1048514A1 (en) 2003-04-04
SI1222467T1 (sl) 2006-06-30

Similar Documents

Publication Publication Date Title
ID25764A (id) Turunan-turunan ftalamida, atau garam-garamnya untuk insektisida agroholtikultura, dan metode penggunaannya
DE60130043D1 (de) Grundierungszusammensetzung und Beschichtungsverfahren
DE60132732D1 (de) Primerzusammensetzung und Verbindungsverfahren
DE60103218D1 (de) Zugagangspunkt und Verfahren zur Verbindungssteuerung
DE60010923D1 (de) Vernetzbare kautschukzusammensetzung und vernetzter gegenstand
AU2001252973A1 (en) Biosensor and related method
HUP0300371A3 (en) Tag library compounds, compositions, kits and methods of use
ID29335A (id) Aparatus dan metode pengontrolan
DE69928874D1 (de) Tonerzusammensetzung, Entwickler und Herstellungsverfahren
ID24997A (id) Kopolimer dan penggunaan sebagai bahan-bahan penolong pengeboran
AU2001288249A1 (en) Biosensors and methods for their use
MXPA03007827A (es) Metodo y composicion para la coloracion permanente gradual de cabello.
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2002243391A1 (en) Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
ID22956A (id) Sintesa disulfida dan polisulfida organik
AU2001274817A1 (en) Agents that modulate dna-pk activity and methods of use thereof
EP1183011A4 (fr) Methode, compositions pharmaceutiques et trousse de traitement de l'angine et/ou d'equivalents angineux
EE200200282A (et) Keemilised meetodid ja vaheühendid
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE60215326D1 (de) Mischsystem und -verfahren
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
AU5122500A (en) Detection of biological warfare agents
NO20021604L (no) Leptin assay
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AU2001256892A1 (en) Reagent for detection of biomolecules, and use thereof